Comparison between Medplus Health IPO and Supriya Lifescience IPO.
Medplus Health IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Medplus Health IPO is up to ₹1,398.29 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Medplus Health IPO is ₹796.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
| Medplus Health IPO | Supriya Lifescience IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹780.00 per share | ₹265.00 per share |
| Issue Price (Upper) | ₹796.00 per share | ₹274.00 per share |
| Issue Price (Final) | ₹796.00 per share | ₹274.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹78.00 per share | |
| Market Lot Size | 18 shares | 54 shares |
| Fresh Issue Size | 75,44,511 shares | 72,99,270 shares |
| Fresh Issue Size (Amount) | up to ₹600.31 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 1,00,28,831 shares | 1,82,48,175 shares |
| OFS Issue Size (Amount) | up to ₹797.98 Cr | up to ₹500.00 Cr |
| Issue Size Total | 1,75,73,342 shares | 2,55,47,445 shares |
| Issue Size Total (Amount) | up to ₹1,398.29 Cr | up to ₹700.00 Cr |
Medplus Health IPO opens on Dec 13, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Medplus Health IPO and Supriya Lifescience IPO is Dec 15, 2021, and Dec 20, 2021, respectively.
| Medplus Health IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Dec 10, 2021 | Dec 15, 2021 |
| Issue Open | Dec 13, 2021 | Dec 16, 2021 |
| Issue Close | Dec 15, 2021 | Dec 20, 2021 |
| Basis Of Allotment (Tentative) | Dec 20, 2021 | Dec 23, 2021 |
| Initiation of Refunds (Tentative) | Dec 21, 2021 | Dec 24, 2021 |
| Credit of Share (Tentative) | Dec 22, 2021 | Dec 27, 2021 |
| Listing date (Tentative) | Dec 23, 2021 | Dec 28, 2021 |
| Anchor Lockin End date 1 | Jan 19, 2022 | Jan 22, 2022 |
| Anchor Lockin End date 2 | Mar 20, 2022 | Mar 23, 2022 |
Medplus Health IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
| Medplus Health IPO | Supriya Lifescience IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 43.16 | 99.98 | ||||
| Promoter Shareholding (Post-Issue) | 40.43 | 68.24 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹9496.73 Cr. | ₹700.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Medplus Health IPO Retail Individual Investors (RII) are offered 61,26,297 shares while in Supriya Lifescience IPO retail investors are offered 61,26,297 shares. Qualified Institutional Buyers (QIB) are offered 35,00,741 shares in Medplus Health IPO and 76,64,234 shares in Supriya Lifescience IPO.
| Medplus Health IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 52,51,111 shares | 1,14,96,351 shares |
| Market Maker Reservation | ||
| QIB | 35,00,741 shares | 76,64,234 shares |
| NII | 26,25,556 shares | 38,32,116 shares |
| RII | 61,26,297 shares | 25,54,744 shares |
| Employee | 69,637 shares | |
| Others | ||
| Total | 1,75,73,342 shares | 2,55,47,445 shares |
Medplus Health IPO subscribed 52.59x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
| Medplus Health IPO | Supriya Lifescience IPO | |
|---|---|---|
| QIB (times) | 111.90x | 31.83x |
| NII (times) | 85.33x | 161.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 5.24x | 56.01x |
| Employee (times) | 3.05x | |
| Other (times) | ||
| Total (times) | 52.59x | 71.51x |
